Brand Name Drugs Rise in Price; Generics Go Down

Tuesday, June 08, 2010

While Congress struggled to adopt national healthcare reform throughout last year and into the beginning of 2010, pharmaceutical manufacturers continued to hike the price of name-brand medications.

An analysis of drug prices by the AARP Public Policy Institute revealed that brand name drugs rose more than 9% from March 2009 to March 2010—despite the fact that inflation was close to zero for consumer goods.
Some individual medications rocketed even higher during the one-year period under review. Flomax, for example, leaped 27.6% in cost.
Although brand name pharmaceuticals went up in price, generic drugs fell by an average of 9%.
-David Wallechinsky


Leave a comment